Jfc. Tomee et al., ANTILEUKOPROTEASE - AN ENDOGENOUS PROTEIN IN THE INNATE MUCOSAL DEFENSE AGAINST FUNGI, The Journal of infectious diseases, 176(3), 1997, pp. 740-747
Previous studies have suggested that endogenous protease inhibitors ma
y participate in the mucosal host defense. Antileukoprotease (ALP) is
an important protease inhibitor found on various mucosal surfaces, inc
luding those of the respiratory and genital tracts. This study reports
on the antimicrobial activity of recombinant (r) ALP toward the human
fungal pathogens Aspergillus fumigatus and Candida albicans. rALP exp
ressed pronounced fungicidal activity toward metabolically active A. f
umigatus conidia and C. albicans yeast cells; however, metabolically q
uiescent A. fumigatus conidia were totally resistant. In contrast with
the protease inhibitory activity of rALP, the fungicidal activity was
localized primarily in the NH2-terminal domain. On a molar base, the
fungicidal activity of rALP was comparable with that of human defensin
s and lysozyme. In addition, rALP caused inhibition of C. albicans yea
st cell growth. By exhibiting antifungal activity, ALP may play an imp
ortant role in the innate mucosal defense against human pathogenic fun
gi.